Prestige Consumer Healthcare Inc. Stock
A very strong showing by Prestige Consumer Healthcare Inc. today, with an increase of €1.80 (4.130%) compared to yesterday's price.
Our community is currently high on Prestige Consumer Healthcare Inc. with 4 Buy predictions and 0 Sell predictions.
As a result the target price of 61 € shows a positive potential of 34.36% compared to the current price of 45.4 € for Prestige Consumer Healthcare Inc..
Pros and Cons of Prestige Consumer Healthcare Inc. in the next few years
Pros
?
C******** o* t** e**********
?
W********* I********* f** t** n*** y****
?
S********** s********
Cons
?
M***** P*******
?
B****
?
G***** c******* t* c**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Prestige Consumer Healthcare Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Prestige Consumer Healthcare Inc. | 4.130% | 0.450% | 4.695% | -29.206% | -16.636% | -26.281% | -3.463% |
| Apollo Medical Holdings, Inc. | -0.650% | -2.532% | -27.700% | 60.417% | 45.283% | -9.942% | -61.258% |
| Petmed Express Inc | -1.980% | -1.992% | -1.768% | -37.563% | -40.333% | -85.715% | -93.076% |
| Suzuken Co Ltd | 1.540% | -8.451% | -1.515% | 4.000% | -20.732% | 4.000% | 6.557% |
Comments
Prestige Consumer Healthcare (PBH) had its price target lowered by Canaccord Genuity Group Inc. from $86.00 to $72.00. They now have a "buy" rating on the stock.
Show more
Ratings data for PBH provided by MarketBeat
Prestige Consumer Healthcare (PBH) had its price target lowered by Oppenheimer Holdings, Inc. from $77.00 to $65.00. They now have an "outperform" rating on the stock.
Show more
Ratings data for PBH provided by MarketBeat
Prestige Consumer Healthcare (NYSE:PBH) had its price target lowered by analysts at Oppenheimer Holdings, Inc. from $82.00 to $72.00. They now have an "outperform" rating on the stock.
Show more
Ratings data for PBH provided by MarketBeat